SubHero Banner

Tymlos (abaloparatide) – New drug approval

April 28, 2017 – Radius Health announced the FDA approval of Tymlos (abaloparatide) injection for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy.

Download PDF